Could a growth factor patch fix eardrums without surgery?

NCT ID NCT02307916

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 2 trial tested whether a gel containing human fibroblast growth factor-2 (FGF-2) can safely close chronic holes in the eardrum. Fifty-seven adults with dry eardrum perforations lasting over 3 months received either the FGF-2 gel or a placebo saline patch, with up to three treatments. The main goal was to see if the hole closed completely, with hearing tests as secondary measures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fibroblast Growth Factor-2 (FGF-2) applied on a gelatin foam patch with fibrin glue
What this could lead to
If it works, this could provide a simple, non-surgical way to close chronic eardrum holes, potentially restoring hearing and reducing infection risk.
What could go wrong
This is a small Phase 2 trial with only 57 people, so results may not apply to everyone. The treatment may not close the hole, and risks like infection or incomplete healing exist.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYMPANIC MEMBRANE PERFORATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Tympanic Membrane Perforation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts Eye and Ear

    Boston, Massachusetts, 02114, United States

  • Wilford Hall, Lackland Airforce Base

    Lackland City, Texas, 78236, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.